Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michele Ceribelli
Affiliation
National Center for Advancing Translational Sciences
ORCID
Career Start Year
2004
Papers
44
H Index
27
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36883564
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer.
JCI Insight
2023
37858338
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.
Cell Rep Med
2023
37627061
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
Cancers (Basel)
2023
37216280
Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
Mol Cancer Ther
2023
37348462
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics.
Cell Syst
2023
37380628
A landscape of response to drug combinations in non-small cell lung cancer.
Nat Commun
2023
37141112
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.
Cancer Discov
2023
37140427
CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.
Cancer Res
2023
34624079
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
Blood
2022
35754026
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.
J Exp Clin Cancer Res
2022
36192480
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
Nat Commun
2022
36115844
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
Nat Commun
2022
33271120
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.
Immunity
2021
33848478
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
Cancer Cell
2021
34778802
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.
Blood Cancer Discov
2021
34767771
Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1.
Mol Cell
2021
34296206
KiRNet: Kinase-centered network propagation of pharmacological screen results.
Cell Rep Methods
2021
31748226
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.
Sci Transl Med
2019
30057145
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Cancer Cell
2018
29925955
A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
Nature
2018
27986456
Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification.
Immunity
2017
28899971
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.
Clin Cancer Res
2017
28552327
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Cancer Cell
2017
27070702
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Cancer Cell
2016
27846392
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Cancer Cell
2016
27799566
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A
2016
26231120
Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.
Immunity
2015
24155397
Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.
J Virol
2014
24980046
ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2.
J Exp Med
2014
25049379
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Proc Natl Acad Sci U S A
2014
24492847
Oncogenic mechanisms in Burkitt lymphoma.
Cold Spring Harb Perspect Med
2014
24491438
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.
Cancer Discov
2014
23431138
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.
Proc Natl Acad Sci U S A
2013
24101375
Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells.
J Exp Med
2013
22885699
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Nature
2012
22698399
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.
Cancer Cell
2012
21934679
Malignant pirates of the immune system.
Nat Immunol
2011
19690168
NF-YC complexity is generated by dual promoters and alternative splicing.
J Biol Chem
2009
18446193
An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters.
PLoS One
2008
18212061
The histone-like NF-Y is a bifunctional transcription factor.
Mol Cell Biol
2008
17003378
The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes.
Blood
2007
16721047
Repression of new p53 targets revealed by ChIP on chip experiments.
Cell Cycle
2006
15961672
Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters.
Mol Pharmacol
2005
15459184
NF-Y regulates the antisense promoter, bidirectional silencing, and differential epigenetic marks of the Kcnq1 imprinting control region.
J Biol Chem
2004
1 - 44 of 44
Column Actions
Search
Recommended Authors
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year
2010
Number of shared co-authors
5
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Jun Qi
Dana-Farber Cancer Institute
Career Start Year
2010
Number of shared co-authors
5
Benjamin G Barwick
Emory University School of Medicine
Career Start Year
2009
Number of shared co-authors
0
Presha Rajbhandari
Columbia University
Career Start Year
2009
Number of shared co-authors
4
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Richard Mitter
The Francis Crick Institute
Career Start Year
2008
Number of shared co-authors
1
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Anderly C Chueh
Biomedicine Discovery Institute, Monash University
Career Start Year
2005
Number of shared co-authors
0
Richard Koche
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
6
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
1
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year
2004
Number of shared co-authors
1
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
1
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
9
Hans-J??rg Warnatz
Max Planck Institute for Molecular Genetics
Career Start Year
2002
Number of shared co-authors
0
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
4
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year
2001
Number of shared co-authors
0
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
1
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year
2000
Number of shared co-authors
4
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
1
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year
1999
Number of shared co-authors
0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
4
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1997
Number of shared co-authors
12
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1991
Number of shared co-authors
0
Ricky W Johnstone
The University of Melbourne
Career Start Year
1990
Number of shared co-authors
2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year
1989
Number of shared co-authors
5
Kristian Helin
The Institute of Cancer Research
Career Start Year
1988
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers
23
Louis M Staudt
National Cancer Institute, National Institutes of Health
Co-authored papers
21
Xiaohu Zhang
National Center for Advancing Translational Sciences
Co-authored papers
9
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers
8
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
7
Roberto Mantovani
Universita` degli Studi di Milano
Co-authored papers
7
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers
7
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers
5
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers
5
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers
5
Sam Michael
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
4
Yves Pommier
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Diletta Dolfini
Universita degli Studi di Milano
Co-authored papers
2
Raffaella Gatta
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Co-authored papers
2
Jun S Wei
Center for Cancer Research, National Cancer Institute
Co-authored papers
2
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers
2
Mirit I Aladjem
National Cancer Institute, Center for Cancer Research
Co-authored papers
2
Henning Urlaub
Max Planck Institute for Multidisciplinary Sciences
Co-authored papers
2
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Co-authored papers
2
Dario R Alessi
Co-authored papers
1
Jesse H Arbuckle
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
1
Michelle Monje
Co-authored papers
1
Fausto J Rodriguez
University of California Los Angeles
Co-authored papers
1
Ty C Voss
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
1
Giacomo Donati
Universita di Torino
Co-authored papers
1
Joshua D Rabinowitz
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers
1
Augustin Luna
Harvard Medical School
Co-authored papers
1
Angela Tam
Co-authored papers
1
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers
1
1 - 30